10.08.2013 Views

status quo of quo vadis? - KCE

status quo of quo vadis? - KCE

status quo of quo vadis? - KCE

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>KCE</strong> Reports 76 Quality development in general practice in Belgium: <strong>status</strong> <strong>quo</strong> or <strong>quo</strong> <strong>vadis</strong> ? 57<br />

Ten key issues can be identified for developing the framework. All stakeholders need to<br />

be involved in the development and the validation process <strong>of</strong> this framework in order to<br />

achieve success. The German and UK examples learn that legislation coupled with<br />

specific financial incentives is a powerful stimulus.<br />

4.3.1 Need for pr<strong>of</strong>essional culture change<br />

The GPs should continuously bear in mind the importance <strong>of</strong> quality improvement<br />

principles when performing their daily work. GPs should become familiar with the<br />

concepts <strong>of</strong> quality development, measurement <strong>of</strong> indicators and the use <strong>of</strong> the quality<br />

cycle.<br />

The involvement <strong>of</strong> GP opinion leaders and scientific bodies is the most critical<br />

precondition to succeed in quality development initiatives at the individual, practice,<br />

regional and national levels. Australia is the most outstanding example <strong>of</strong> the power <strong>of</strong><br />

the pr<strong>of</strong>ession to launch effective quality programs. Opinion leaders <strong>of</strong> general practice<br />

in the UK, Australia and the Netherlands closely interact with the academics. The GP<br />

opinion and scientific leaders in these countries outlined the concepts <strong>of</strong> the quality<br />

development programmes and subsequently marketed these to the pr<strong>of</strong>essional bodies.<br />

In Belgium, academic departments and scientific bodies also have to take up their<br />

position in the quality debate. They must define the content <strong>of</strong> the quality initiatives and<br />

how the pr<strong>of</strong>ession will achieve their successful implementation.<br />

4.3.2 Health Authorities in a future quality system<br />

The role <strong>of</strong> the Health Authorities is first to address a quality policy that deals with<br />

priority aspects and anticipates the different steps from data collection to the use <strong>of</strong><br />

results for further improvement. Authorities must also define the tools that should be<br />

promoted for quality improvement in general practice. The choice <strong>of</strong> the most<br />

appropriate tools must adhere to the scientific literature and experience from other<br />

countries, as described in this report.<br />

A very powerful drive for change is a legal framework that introduces the requirements<br />

for quality development. The UK and Dutch pr<strong>of</strong>essional bodies have referred to<br />

implicit thread <strong>of</strong> formal regulations on quality. The UK and Australia are successful<br />

illustrations <strong>of</strong> the need for a pre-existing legal framework. The consequences <strong>of</strong><br />

registration <strong>of</strong> data for quality measurement will be clearly determined beforehand.<br />

Political will and leadership are needed to put the development <strong>of</strong> quality in general<br />

practice on the political agenda, including the specification <strong>of</strong> a time frame in which<br />

general practice should adhere to a quality development scheme.<br />

Furthermore the Authorities have a facilitating role:<br />

• To support a platform that will collect the data and to create an independent<br />

trustworthy body that will provide feedbacks to the GPs and stakeholders;<br />

• To promote and financially support standardised IT equipment that allows the<br />

collection <strong>of</strong> routine data for the measurement <strong>of</strong> quality indicators.<br />

4.3.3 Stakeholders<br />

All countries that have adopted successful quality development strategies have a finely<br />

tuned interaction between the key groups influencing the choice <strong>of</strong> quality measures i.e.<br />

purchasers, patients and physicians. 17 For Belgium the following stakeholders could take<br />

part in quality development i.e., general practitioners, scientific GP bodies, regional<br />

organisations <strong>of</strong> general practice, academic departments <strong>of</strong> general practice, other<br />

organisations <strong>of</strong> primary health care like nursing and regional multi-pr<strong>of</strong>essional bodies,<br />

GP unions, sickness funds and the Intermutualistic agency (IMA/AMI), INAMI/RIZIV,<br />

organisations <strong>of</strong> patients and s<strong>of</strong>tware suppliers.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!